Skip to main content
letter
. 2020 Dec 29;22(3):511–513.e3. doi: 10.1016/j.jamda.2020.12.028

Supplementary Table 2.

The Course of the 12 Most Frequently (≥20%) Reported Signs and Symptoms, Per Tract

Sign/symptom Day Start
Duration Until Decrease (d)
Duration Until Full Recovery (d)
n Median (IQR) n Median (IQR) n Median (IQR)
Respiratory
 Cough 68 0 (0–4) 38 9 (2–16) 34 18 (7–26)
 Shortness of breath 52 3 (1–5) 26 7 (1–12) 18 15 (5–21)
 Rhinorrhea/nasal congestion 33 2 (0–9) 8 5 (1–8) 8 6 (1–15)
 Sore throat 18 2 (0–7) 3 3 (–) 4 12 (–)
General
 Malaise/fatigue 73 0 (0–4) 34 12 (6–20) 28 17 (10–25)
 Fever 67 1 (0–4) Not applicable 51 3 (1–9)
 Loss of appetite/decreased intake 64 3 (1–7) 28 8 (3–13) 27 13 (7–19)
 Decreased mobility 54 3 (1–6) 17 12 (4–17) 11 17 (3–22)
Gastrointestinal
 Diarrhea 41 4 (1–7) 24 3 (1–13) 22 7 (1–19)
 Nausea/vomiting 32 5 (2–8) 21 1 (1–12) 19 1 (1–16)
Neurological/behavior
 Change in behavior 22 3 (1–5) 10 5 (3–8) 9 8 (4–11)
 Confusion/delirium 18 8 (4–10) 8 5 (3–19) 6 11 (3–24)

The durations until decrease and full recovery of signs and symptoms are based on a smaller group of residents, because a group of residents died before decrease and/or full recovery.

No IQR available because of the small number of observations.